Citation Impact
Citing Papers
Cardiac Hypertrophy: The Good, the Bad, and the Ugly
2003 Standout
Clinical Practice Guidelines for the Management Candidiasis: 2009 Update by the Infectious Diseases Society of America
2009 Standout
Epidemiology of Invasive Candidiasis: a Persistent Public Health Problem
2007 Standout
Rapid Host Defense against Aspergillus fumigatus Involves Alveolar Macrophages with a Predominance of Alternatively Activated Phenotype
2011
Bump-and-Hole Engineering Identifies Specific Substrates of Glycosyltransferases in Living Cells
2020 StandoutNobel
Hypoxia — a key regulatory factor in tumour growth
2002 Standout
Generation of IL-23 Producing Dendritic Cells (DCs) by Airborne Fungi Regulates Fungal Pathogenicity via the Induction of TH-17 Responses
2010
Leukocyte Migration into Inflamed Tissues
2014
The re-emergence of natural products for drug discovery in the genomics era
2015 Standout
Myeloid-derived suppressor cells coming of age
2018 Standout
Vulvovaginal candidosis
2007 Standout
Identification of the molecular basis of doxorubicin-induced cardiotoxicity
2012 Standout
Constraints-based genome-scale metabolic simulation for systems metabolic engineering
2009
Cancer nanomedicine: progress, challenges and opportunities
2016 Standout
Gi-Coupled GPCR Signaling Controls the Formation and Organization of Human Pluripotent Colonies
2009 StandoutNobel
Calcium's Role in Mechanotransduction during Muscle Development
2014 Standout
CNS pharmacokinetics of antifungal agents
2007
Early cardiac hypertrophy in mice with impaired calmodulin regulation of cardiac muscle Ca2+ release channel
2007 StandoutNobel
Protein kinase cascades in the regulation of cardiac hypertrophy
2005
Calcineurin and hypertrophic heart disease: novel insights and remaining questions
2002
Hypoxia-associated Induction of Early Growth Response-1 Gene Expression
1999
Molecular distinction between physiological and pathological cardiac hypertrophy: Experimental findings and therapeutic strategies
2010
Derangement of the endothelial glycocalyx in sepsis
2018
Chronic inhibition of cyclic GMP phosphodiesterase 5A prevents and reverses cardiac hypertrophy
2005 Standout
Adult Cardiac Stem Cells Are Multipotent and Support Myocardial Regeneration
2003 Standout
Regulation of cardiac hypertrophy in vivo by the stress-activated protein kinases/c-Jun NH2-terminal kinases
1999
Pressure-independent enhancement of cardiac hypertrophy in natriuretic peptide receptor A–deficient mice
2001 StandoutNobel
Cardiac hypertrophy and failure: lessons learned from genetically engineered mice
2001
Anidulafungin: an echinocandin antifungal
2004
Mechanotransduction in Cardiac Myocytes
2004
The use of mannan antigen and anti-mannan antibodies in the diagnosis of invasive candidiasis: recommendations from the Third European Conference on Infections in Leukemia
2010
Review of Newer Antifungal and Immunomodulatory Strategies for Invasive Aspergillosis
2003
Caspofungin versus Liposomal Amphotericin B for Empirical Antifungal Therapy in Patients with Persistent Fever and Neutropenia
2004
Biological roles of glycans
2016 Standout
Protein Kinase C-β and Oxygen Deprivation
2000
The echinocandin antifungals: an overview of the pharmacology, spectrum and clinical efficacy
2003
Heme Oxygenase-1/Carbon Monoxide: From Basic Science to Therapeutic Applications
2006 Standout
Transgenesis and cardiac energetics: new insights into cardiac metabolism
2004
Systems-level antimicrobial drug and drug synergy discovery
2013
Myocardial Substrate Metabolism in the Normal and Failing Heart
2005 Standout
Echinocandin antifungal drugs
2003 Standout
Confronting the Challenges of Natural Product-Based Antifungal Discovery
2011
Clinical breakpoints for the echinocandins and Candida revisited: Integration of molecular, clinical, and microbiological data to arrive at species-specific interpretive criteria
2011
The clinical impact of glycobiology: targeting selectins, Siglecs and mammalian glycans
2021 StandoutNobel
Antifungal drugs in pregnancy: a review
2003
Diabetic cardiomyopathy: recent evidence from mouse models of type 1 and type 2 diabetes
2004
Implications of heparan sulfate and heparanase in neuroinflammation
2014
Free radicals and antioxidants in normal physiological functions and human disease
2006 Standout
Generating Conditional Mouse Mutants via Tetracycline-Controlled Gene Expression
2003
Newer triazole antifungal agents: pharmacology, spectrum, clinical efficacy and limitations
2006
The many roles of histone deacetylases in development and physiology: implications for disease and therapy
2008 Standout
Molecular Mechanisms of Cardiac Hypertrophy Induced by Toxicants
2001
Mammalian G Proteins and Their Cell Type Specific Functions
2005
The MEK1-ERK1/2 signaling pathway promotes compensated cardiac hypertrophy in transgenic mice
2000
Compound Prioritization Methods Increase Rates of Chemical Probe Discovery in Model Organisms
2011
Calcineurin Promotes Protein Kinase C and c-Jun NH2-terminal Kinase Activation in the Heart
2000
Functional Fluorescent Ca2+ Indicator Proteins in Transgenic Mice under TET Control
2004 StandoutNobel
What is flux balance analysis?
2010 Standout
Seven-transmembrane-spanning receptors and heart function
2002 StandoutNatureNobel
Neutrophils: Between Host Defence, Immune Modulation, and Tissue Injury
2015
Protective and pathogenic functions of macrophage subsets
2011 Standout
Increasing Echinocandin Resistance in Candida glabrata: Clinical Failure Correlates With Presence of FKS Mutations and Elevated Minimum Inhibitory Concentrations
2013
Plasminogen Alleles Influence Susceptibility to Invasive Aspergillosis
2008
Cardiac hypertrophy, sorting out the circuitry
1999
Regulation of cardiac hypertrophy by intracellular signalling pathways
2006 Standout
Autoantibodies against cardiac troponin I are responsible for dilated cardiomyopathy in PD-1-deficient mice
2003 StandoutNobel
Immunity to fungal infections
2011 Standout
Activation of protein kinase cascades in the heart by hypertrophic G protein–coupled receptor agonists
1999
Quantitative Super-Resolution Microscopy of the Mammalian Glycocalyx
2019 StandoutNobel
Inhibition of Spontaneous β2-Adrenergic Activation Rescues β1-Adrenergic Contractile Response in Cardiomyocytes Overexpressing β2-Adrenoceptor
2000 StandoutNobel
Antifungal Drug Development: Challenges, Unmet Clinical Needs, and New Approaches
2014
Endothelial-to-mesenchymal transition contributes to cardiac fibrosis
2007 Standout
Posaconazole vs. Fluconazole or Itraconazole Prophylaxis in Patients with Neutropenia
2007 Standout
Cardiac excitation–contraction coupling
2002 StandoutNature
CNS pharmacokinetics of antifungal agents
2007
Role of the endothelial surface layer in neutrophil recruitment
2015
Fibrosis, not cell size, delineates β-myosin heavy chain reexpression during cardiac hypertrophy and normal aging in vivo
2006 StandoutNobel
Signaling in Myocardial Hypertrophy
1999
Reengineering Inducible Cardiac-Specific Transgenesis With an Attenuated Myosin Heavy Chain Promoter
2003
Azole-Based Energetic Salts
2011 Standout
Myocardial Fatty Acid Metabolism in Health and Disease
2010 Standout
Genetic Dissection of Cardiac Growth Control Pathways
2000
Troponin and Tropomyosin
1998
Caspofungin
2003
Cardiac-Specific Expression of Heme Oxygenase-1 Protects Against Ischemia and Reperfusion Injury in Transgenic Mice
2001
Laboratory diagnosis of invasive aspergillosis
2005
Clinical Practice Guideline for the Use of Antimicrobial Agents in Neutropenic Patients with Cancer: 2010 Update by the Infectious Diseases Society of America
2011 Standout
Cardiac hypertrophy and sudden death in mice with a genetically clamped renin transgene
2004 StandoutNobel
Next Generation of Fluorine-Containing Pharmaceuticals, Compounds Currently in Phase II–III Clinical Trials of Major Pharmaceutical Companies: New Structural Trends and Therapeutic Areas
2016 Standout
Adaptive and Maladaptive Cardiorespiratory Responses to Continuous and Intermittent Hypoxia Mediated by Hypoxia-Inducible Factors 1 and 2
2012 StandoutNobel
Pharmacodynamics of Caspofungin in a Murine Model of Invasive Pulmonary Aspergillosis: Evidence of Concentration‐Dependent Activity
2004
Influences of Methodological Variables on Susceptibility Testing of Caspofungin against Candida Species and Aspergillus fumigatus
2003
Invasive Candidiasis
2015 Standout
Clinical Practice Guideline for the Management of Candidiasis: 2016 Update by the Infectious Diseases Society of America
2015 Standout
From the Sarcomere to the Nucleus: Role of Genetics and Signaling in Structural Heart Disease
2000
Cytoplasmic Signaling Pathways That Regulate Cardiac Hypertrophy
2001
Isavuconazole (BAL4815) Pharmacodynamic Target Determination in an In Vivo Murine Model of Invasive Pulmonary Aspergillosis against Wild-Type and cyp51 Mutant Isolates of Aspergillus fumigatus
2013
Altered focal adhesion regulation correlates with cardiomyopathy in mice expressing constitutively active rac1
2000
Phosphoinositide 3-kinase(p110α) plays a critical role for the induction of physiological, but not pathological, cardiac hypertrophy
2003
PKCα regulates the hypertrophic growth of cardiomyocytes through extracellular signal–regulated kinase1/2 (ERK1/2)
2002
Worldwide emergence of resistance to antifungal drugs challenges human health and food security
2018 StandoutScience
PKC-β is not necessary for cardiac hypertrophy
2001
Ferroptosis as a target for protection against cardiomyopathy
2019 Standout
COVID-19 and its implications for thrombosis and anticoagulation
2020 Standout
The in vivo role of p38 MAP kinases in cardiac remodeling and restrictive cardiomyopathy
2001
Increased contractility and altered Ca2+ transients of mouse heart myocytes conditionally expressing PKCβ
2001
On the pivotal role of PPARa in adaptation of the heart to hypoxia and why fat in the diet increases hypoxic injury
2016 StandoutNobel
Inflammation and metabolism in tissue repair and regeneration
2017 StandoutScience
Temporally Regulated and Tissue-Specific Gene Manipulations in the Adult and Embryonic Heart Using a Tamoxifen-Inducible Cre Protein
2001
Protein Kinases C and D Mediate Agonist-Dependent Cardiac Hypertrophy through Nuclear Export of Histone Deacetylase 5
2004
Role of Extracellular Matrix in Adaptation of Tendon and Skeletal Muscle to Mechanical Loading
2004 Standout
Cardiac transgenic and gene-targeted mice as models of cardiac hypertrophy and failure: A problem of (new) riches
1998
Works of Joel Bowman being referenced
The pulmonary endothelial glycocalyx regulates neutrophil adhesion and lung injury during experimental sepsis
2012
Expression and regulation of mutant forms of cardiac TnI in a reconstituted actomyosin system: Role of kinase dependent phosphorylation
1997
Essential Gene Identification and Drug Target Prioritization in Aspergillus fumigatus
2007
Expression of protein kinase C beta in the heart causes hypertrophy in adult mice and sudden death in neonates.
1997
Quantitative PCR Assay To Measure Aspergillus fumigatus Burden in a Murine Model of Disseminated Aspergillosis: Demonstration of Efficacy of Caspofungin Acetate
2001
Long-term expression of protein kinase C in adult mouse hearts improves postischemic recovery
1999
The Antifungal Echinocandin Caspofungin Acetate Kills Growing Cells of Aspergillus fumigatus In Vitro
2002
Caspofungin Inhibits Rhizopus oryzae 1,3-β- d -Glucan Synthase, Lowers Burden in Brain Measured by Quantitative PCR, and Improves Survival at a Low but Not a High Dose during Murine Disseminated Zygomycosis
2005